Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder
- Conditions
- Depressive DisorderDepressionDepressive Disorder, Major
- First Posted Date
- 2015-06-09
- Last Posted Date
- 2020-04-30
- Lead Sponsor
- Assurex Health Inc.
- Target Recruit Count
- 542
- Registration Number
- NCT02466477
- Locations
- 🇨🇦
Chatham-Kent Clinical Trials Research Center, Chatham, Ontario, Canada
🇨🇦Hamilton Community Health Centre Family Health Organization, Hamilton, Ontario, Canada
🇨🇦Hamilton Medical Research Group, Hamilton, Ontario, Canada
Genomics Used to Improve DEpression Decisions
- Conditions
- Major Depressive Disorder (MDD)
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- Assurex Health Inc.
- Target Recruit Count
- 1398
- Registration Number
- NCT02109939
- Locations
- 🇺🇸
Birmingham Psychiatry Pharmaceutical Studies, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸CiTrials, Riverside, California, United States
Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm
- Conditions
- DepressionAnxiety
- First Posted Date
- 2012-07-02
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- Assurex Health Inc.
- Target Recruit Count
- 104
- Registration Number
- NCT01632267
- Locations
- 🇺🇸
Union Health Services, Chicago, Illinois, United States
Pharmacogenetic-Directed Treatment for Major Depression
- Conditions
- Depression
- First Posted Date
- 2010-12-16
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- Assurex Health Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT01261364